Stent News and Research RSS Feed - Stent News and Research

A stent is a small mesh tube that’s used to treat narrowed or weakened arteries in the body.

You may have a stent placed in an artery as part of a procedure called angioplasty (AN-jee-oh-plas-tee). Angioplasty can restore blood flow through narrowed or blocked arteries. Stents help prevent arteries from becoming narrowed or blocked again in the months or years after treatment with angioplasty. You may also have a stent placed in a weakened artery to improve blood flow and to help prevent the artery from bursting.

Stents are usually made of metal mesh, but sometimes they’re made of fabric. Fabric stents, also called stent grafts, are used in larger arteries. Some stents are coated with medicines that are slowly and continuously released into the artery. These medicines help prevent the artery from becoming blocked again.
NTNU researchers testing use of new removable stent in the lungs

NTNU researchers testing use of new removable stent in the lungs

A knitted rag sock inspired this professor and MD to develop a stent that can easily be removed after it has done its job. [More]
Genetic testing at UMMC helps doctors identify effective medication for heart stent patients

Genetic testing at UMMC helps doctors identify effective medication for heart stent patients

The University of Maryland Medical Center is now offering a simple genetic test to patients who receive heart stents to determine whether they have a genetic deficiency that affects how they respond to a common drug to prevent blood clots. [More]
Researchers uncover reason for stent failure in diabetic patients with clogged arteries

Researchers uncover reason for stent failure in diabetic patients with clogged arteries

People with any form of diabetes are at greater risk of developing cardiovascular conditions than people without the disease. Moreover, if they undergo an operation to open up a clogged artery by inserting a "stent" surgical tube, the artery is much more likely to clog up again. [More]
Blood flow modeling through stents ignites passion for biomedical engineering

Blood flow modeling through stents ignites passion for biomedical engineering

An interest in solving complex problems, friends training to be medical doctors and his father having a stroke helped put John Asiruwa on the path to becoming a biomedical engineer. [More]
Innovation in stroke aftercare across Europe: an interview with Professor Urs Fischer

Innovation in stroke aftercare across Europe: an interview with Professor Urs Fischer

Stroke is the epidemic disease of the twenty-first century and the second most frequent cause of death in 2011, accounting for 11% of all deaths worldwide. Stroke is also the second most important cause of permanent disability and... [More]
Thousands of patients could benefit from highly effective stroke treatment, research shows

Thousands of patients could benefit from highly effective stroke treatment, research shows

Almost 10,000 UK stroke patients a year could benefit from a new procedure, according to research presented today at the UK Stroke Forum Conference in Liverpool. [More]
Allergan gets FDA approval for new XEN Glaucoma Treatment System

Allergan gets FDA approval for new XEN Glaucoma Treatment System

Allergan plc announced today the U.S. Food and Drug Administration has cleared the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) for use in the U.S. [More]
OrbusNeich launches new Dual Therapy Stent for active vessel healing

OrbusNeich launches new Dual Therapy Stent for active vessel healing

OrbusNeich has announced the launch of its latest generation Dual Therapy Stent (DTS), the COMBO Plus. [More]
New treatment strategy effective in preventing bleeding in AF patients who underwent PCI, study shows

New treatment strategy effective in preventing bleeding in AF patients who underwent PCI, study shows

A new study led by clinician-researchers at Beth Israel Deaconess Medical Center testing the safety and effectiveness of anticoagulant strategies for patients with atrial fibrillation who undergo stenting procedures has shown that therapies combining the anticoagulant drug rivaroxaban with either single or dual anti-platelet therapy were more effective in preventing bleeding complications than the current standard of care. [More]
New guidelines recommend use of antiplatelet therapy and exercise program for treatment of PAD

New guidelines recommend use of antiplatelet therapy and exercise program for treatment of PAD

New guidelines for the treatment of peripheral artery disease (PAD), include recommendations on the use of antiplatelet therapy to reduce the risk of blood clots and statin drugs to lower cholesterol and advise PAD patients to participate in a structured exercise program. [More]
Study of new polymer-free DFS indicates non-inferior in-stent late lumen loss at nine-months

Study of new polymer-free DFS indicates non-inferior in-stent late lumen loss at nine-months

A first-in-human study of a new polymer-free drug-filled stent, which provides controlled drug elution from an internal lumen, indicated non-inferior in-stent late lumen loss at nine-months compared with historical zotarolimus-eluting stent (Resolute) data. In addition, there was no binary restenosis, and a high degree of early stent strut coverage with minimal malapposition. [More]
PLATINUM DIVERSITY study evaluates clinical outcomes after stent implantation in women, minorities

PLATINUM DIVERSITY study evaluates clinical outcomes after stent implantation in women, minorities

A dedicated stent study conducted exclusively in women and minority patients evaluated clinical outcomes within the era of contemporary PCI, comparing these results to a parallel cohort of white male patients. [More]
TCT 2016 features first report investigations on novel bioresorbable stents

TCT 2016 features first report investigations on novel bioresorbable stents

The 28th annual Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation featured a number of first report investigations on novel stents that could become the next generation of bioresorbable stents in patients. [More]
Stents can be as effective as surgery for many patients with left main coronary artery disease

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery. [More]
OCT offers safe and better guidance for patients undergoing PCI to treat coronary artery disease

OCT offers safe and better guidance for patients undergoing PCI to treat coronary artery disease

Optical coherence tomography (OCT) provides safe and improved guidance for patients undergoing percutaneous coronary intervention to treat coronary artery disease, according to results from the ILLUMIEN III: OPTIMIZE PCI trial. [More]
Adherence to medical therapy linked to better outcomes for patients who had heart procedures

Adherence to medical therapy linked to better outcomes for patients who had heart procedures

Patients who had a stent procedure or heart bypass surgery and continued with their prescribed medical therapy had significantly better outcomes than non-adherent patients, according to a study published today in the journal Circulation. [More]
Scientists use 3-D printing to develop customized biodegradable stents

Scientists use 3-D printing to develop customized biodegradable stents

Most people have heard about personalized medicine. But how about personalized medical devices? Northwestern Engineering's Guillermo Ameer and Cheng Sun have teamed up to use 3-D printing to develop flexible, biodegradable stents that are customized for a specific patient's body. [More]
UCLA-led study shows treatment can provide benefits up to 7.3 hours after onset of stroke

UCLA-led study shows treatment can provide benefits up to 7.3 hours after onset of stroke

Time is of the essence when getting people stricken with acute ischemic strokes to treatment. And the use of stent retrievers — devices that remove the blood clot like pulling a cork out of a wine bottle — has proven to be a breakthrough for removing the life-threatening blockage of blood flow to the brain. [More]
New software that simulates interventions could spare young heart patients from surgery

New software that simulates interventions could spare young heart patients from surgery

Children with congenital heart defects often undergo a battery of strenuous examinations and interventions. In the EU CARDIOPROOF project, Fraunhofer researchers have developed software to simulate certain interventions in advance. [More]
MedStar Heart & Vascular Institute offers bioresorbable stent for patients with clogged arteries

MedStar Heart & Vascular Institute offers bioresorbable stent for patients with clogged arteries

A heart stent that slowly dissolves into the body is now available for patients with clogged arteries. [More]
Advertisement
Advertisement